search
Back to results

e-GOLIAH in Autistic Spectrum Disorders (e-GOLIAH-ECO)

Primary Purpose

Autism Spectrum Disorder

Status
Not yet recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
"e-GOLIAH"
Usual care
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Autism Spectrum Disorder focused on measuring e-GOLIAH, e-GOLIAH-ECO, Autistic Spectrum Disorders, Children, Tablet, Games, Serious Game

Eligibility Criteria

3 Years - 6 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion criteria :

  • Child with autism confirmed by a validated instrument (ADI-R or ADOS)
  • Aged 3 to 6 years;
  • Parent(s) agree to get involved in the constraint of using the SG 5 times / week at home for 2 periods of 3 months.
  • Signature of the informed consent form by the 2 holders of parental authority or the only holder of parental authority present
  • Affiliation to a social security scheme (except AME)

Non-inclusion criteria :

  • Children with behavioral problems;
  • Unstabilized comorbid organic pathology;
  • Moderate and severe cognitive deficit (Intellectual Quotient less than 55);
  • Multi or polyhandicap.
  • Medication that may cause visual or cognitive impairment (PSAs, neuroleptics, etc.) or that may interfere with the study assessments
  • Degenerative diseases or any other disease that could interfere with the evaluations planned during this study (known epilepsy and/or history of seizures, etc.)
  • Photosensitive persons in order to avoid situations that could induce epileptic seizures in them

Sites / Locations

  • Fondation Lenval - Hôpitaux Pédiatriques de Nice- CHU Lenval
  • Centre Hospitalier Universitaire de Strasbourg
  • Centre Hospitalier Universitaire de Toulouse
  • Centre Hospitalier Universitaire de Montpellier
  • Assistance Publique - Hôpitaux de Paris, Site de la Pitié-Salpêtrière
  • Centre Hospitalier Sainte-Anne / GHU Paris Psychiatrie et Neurosciences
  • Assistance Publique - Hôpitaux de Paris, Site de Necker
  • Centre Hospitalier de Versailles - André Mignot
  • Centre Hospitalier Universitaire de Tours
  • Centre Hospitalier Universitaire de Nancy
  • Centre Hospitalier d'Amiens
  • Centre Hospitalier Universitaire de Paris - Centre Hospitalier d'Henri Laborit

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Experimental

Control

Arm Description

Children receiving the usual care plus intensive use of e-GOLIAH (experimental group)

Children receiving only the usual treatment (control group).

Outcomes

Primary Outcome Measures

Comparison of Incremental Cost-Utility Ratio (ICUR) at 12 months between the 2 groups
ICUR use the 5-level EQ-5D version and the child-friendly EQ-5D version (EQ5D-5L/EQ5D-Y) questionnaires (min score : 0 ; max score : 100 ; higher scores mean a better outcome)

Secondary Outcome Measures

Comparison of Incremental Cost-utility ratio (ICUR) at 6 months between the 2 groups
ICUR use the 5-level EQ-5D version and the child-friendly EQ-5D version (EQ5D-5L/EQ5D-Y) questionnaires (min score : 0 ; max score : 100 ; higher scores mean a better outcome)
Comparison of Incremental cost-effectiveness ratio (ICER) between the 2 groups
ICER use the Vineland II scale (undetermined minimum and maximum)composite score, average score : 100, higher scores mean a better outcome)
Comparison of the out of pocket payment for the consumption of treatments linked to the TSA between the 2 groups
Amount remaining payable by the patient after deduction of reimbursements received by health insurance
Budget impact analysis (BIA) of e-GOLIAH in the management of children diagnosed with TSA for health insurance
Budget impact analysis (BIA) will be measured by direct resources consumed and quantified using the SNIIRAM/SNDS database
Comparison of Quality of life between the 2 groups
Measured by the 5-level EQ-5D version and the child-friendly EQ-5D version measured by proxy EQ-5D-5L/EQ-5D-Y(proxy) for the patient and their parent. Scale 0-100 (min score: 0, max score :100, higher scores mean a better outcome)
Comparison of Adaptive symptoms between the 2 groups
Use the Vineland-II Scale of socio-adaptive behavior measured by the composite score with an average to 100 of 4 dimensions: socialization, communication, life skills everyday life, and motricity (undetermined minimum and maximum composite score, average score : 100, higher scores mean a better outcome)
Comparison of Autistic symptoms between the 2 groups
Use the CARS (Child Autism Rating Ladder) scale, 15 items coded from 1 to 4 (score min: 0, max : 60, higher scores mean a worse outcome)
Comparison of Social interactions between the 2 groups
Use the SRS (Social Responsiveness Scale) scale, 65 items coded from 1 to 4 (score min: 0 ; score max : 260, higher scores mean a worse outcome)
Comparison of Parental Stress between the 2 groups
Use the Parental Stress Index scale, 36 items coded from 1 to 5 (score min : 0 ; max: 180, higher scores mean a worse outcome)
The child's acceptability to the e-GOLIAH game at home
interview with clinical team by phone contact every twice a month for 12 months

Full Information

First Posted
February 28, 2022
Last Updated
April 15, 2022
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
University Hospital, Montpellier
search

1. Study Identification

Unique Protocol Identification Number
NCT05271955
Brief Title
e-GOLIAH in Autistic Spectrum Disorders
Acronym
e-GOLIAH-ECO
Official Title
Medico-economic Evaluation of the Care by Serious Games in Outpatient Units and at Home for Children With Autism Spectrum Disorders
Study Type
Interventional

2. Study Status

Record Verification Date
February 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
June 15, 2022 (Anticipated)
Primary Completion Date
December 15, 2024 (Anticipated)
Study Completion Date
December 15, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
University Hospital, Montpellier

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Randomized open-label study comparing children aged 3 to 6 years with autism and normal cognitive development or mild cognitive impairment receiving the usual treatment plus intensive use of eGOLIAH (experimental group) with children receiving only the usual treatment (control group). eGOLIAH (Gaming Open Library for Intervention in Autism at Home) is an accessible online platform for digital games inspired by the principles of the Early Start Denver Model (ESDM), one of the care programs validated in the management of young ASD. The duration per patient will be one year. The exposure to e-GOLIAH for the experimental group will be done with the recommendation of intensive exposure to the game (5 sessions> ½ hour per week). Clinical variables will be assessed at entry, 6 months and 1 year (end of study). The EQ5D questionnaires will be collected by the supervising therapist during the follow-up visit and at the same time as the clinical variables.
Detailed Description
In a context of increasing prevalence of Autism Spectrum Disorder (ASD) and the heterogeneity of children's profiles and abilities, early diagnosis is crucial in order to implement intensive, individualized, multidimensional therapeutic care and therefore more efficient. In the context of MICHELANGELO (FP7 European Research project), we developed a serious game called GOLIAH for Gaming Open Library for Intervention for Autism at Home. Using the first beta version as functional prototype, we showed that the demonstrator could be used at home with the help of parents in addition to usual care, during a clinical study including 25 participants. Also, Billeci and colleagues showed that, after training, children's improvement in joint attention tasks was correlated with changes in brain activity and connectivity. We then developed a new version e-GOLIAH to open the opportunity to conduct a large clinical study to assess the validity of the tool in terms of children's improvements. The goals of e-GOLIAH are to bring improvements in terms of ergonomics and accessibility to this initial prototype by finalizing the tool and distributing it to therapists, parents and children with ASD, via the Curapy.com web platform. e-GOLIAH provides, in free and open access, a platform for digital games inspired by the principles of ESDM (Early Start Denver Model) allowing intensive training to improve joint attention and imitation, two key skills for early social interaction and communication. It is a more natural, child-centered intervention method practiced at home and involving parents. This innovative solution takes the assessment and management of autism care out of the usual clinical environment. eGOLIAH (Gaming Open Library for Intervention in Autism at Home) is an accessible online platform for digital games that include ten different games with different level of complexity. A key principle is the collaboration between the child and his/her parent to proceed with the games making it interactive by nature, each participant having his own tablet. The current study e-GOLIAH-ECO is a medico-economic study powered to recruit 150 children. It is a multisite randomized open-label study comparing children aged 3 to 6 years with autism and normal cognitive development or mild cognitive impairment receiving the usual treatment plus intensive use of eGOLIAH (experimental group) with children receiving only the usual treatment (control group). The duration per patient will be one year. The exposure to e-GOLIAH for the experimental group will be done with the recommendation of intensive exposure to the game (5 sessions> ½ hour per week). Clinical variables will be assessed at entry, 6 months and 1 year (end of study). The EQ5D (quality of life) questionnaires will be collected by the supervising therapist during the follow-up visit and at the same time as the clinical variables. The main objective is to evaluate the 12-month cost-effectiveness of the management of children diagnosed with ASDs using the e-GOLIAH game used at home, compared to usual management. Secondary objective includes: (i) To evaluate the cost-effectiveness ratio of the management of patients with ASDs using e-GOLIAH compared to usual management at 12 months of follow-up. (ii) To explore the remaining ASD-related annual burden of the cost of disease for the two groups studied. (iii) To evaluate the consequences of the generalization of the management of children diagnosed with ASD using e-GOLIAH, compared to a usual management, from the point of view of the Health Insurance over a period of 3 years. (iv) To evaluate the impact of the management of children diagnosed with ASD using the e-GOLIAH game used at home, compared to usual management, on the patient's quality of life and that of their responsible parent and the correlation between the two, on adaptive symptoms, on autistic symptoms, on social interactions, on parental stress, at 6 months and at 12 months. (v) To assess compliance with OS by children and their caregivers. The following scales will be monitored: the EQ5D-3L for quality of life, the Vineland-II scale, the Child Autism Rating Scale (CARS), the Social Responsiveness Scale (SRS), the Parenting Stress Index. In addition the medico-economic data will be monitored from regular interview and social insurance data.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Autism Spectrum Disorder
Keywords
e-GOLIAH, e-GOLIAH-ECO, Autistic Spectrum Disorders, Children, Tablet, Games, Serious Game

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
150 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Experimental
Arm Type
Experimental
Arm Description
Children receiving the usual care plus intensive use of e-GOLIAH (experimental group)
Arm Title
Control
Arm Type
Active Comparator
Arm Description
Children receiving only the usual treatment (control group).
Intervention Type
Device
Intervention Name(s)
"e-GOLIAH"
Intervention Description
Usual care plus electronic tablet with games application "e-GOLIAH" (Gaming Open Library for Intervention in Autism at Home)
Intervention Type
Behavioral
Intervention Name(s)
Usual care
Intervention Description
Usual care which combines speech therapy, psychomotor, educational or psychological care with a developmental and / or behavioral orientation and a school life support during schooling.
Primary Outcome Measure Information:
Title
Comparison of Incremental Cost-Utility Ratio (ICUR) at 12 months between the 2 groups
Description
ICUR use the 5-level EQ-5D version and the child-friendly EQ-5D version (EQ5D-5L/EQ5D-Y) questionnaires (min score : 0 ; max score : 100 ; higher scores mean a better outcome)
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Comparison of Incremental Cost-utility ratio (ICUR) at 6 months between the 2 groups
Description
ICUR use the 5-level EQ-5D version and the child-friendly EQ-5D version (EQ5D-5L/EQ5D-Y) questionnaires (min score : 0 ; max score : 100 ; higher scores mean a better outcome)
Time Frame
6 months
Title
Comparison of Incremental cost-effectiveness ratio (ICER) between the 2 groups
Description
ICER use the Vineland II scale (undetermined minimum and maximum)composite score, average score : 100, higher scores mean a better outcome)
Time Frame
6 and 12 months
Title
Comparison of the out of pocket payment for the consumption of treatments linked to the TSA between the 2 groups
Description
Amount remaining payable by the patient after deduction of reimbursements received by health insurance
Time Frame
12 months
Title
Budget impact analysis (BIA) of e-GOLIAH in the management of children diagnosed with TSA for health insurance
Description
Budget impact analysis (BIA) will be measured by direct resources consumed and quantified using the SNIIRAM/SNDS database
Time Frame
3 years
Title
Comparison of Quality of life between the 2 groups
Description
Measured by the 5-level EQ-5D version and the child-friendly EQ-5D version measured by proxy EQ-5D-5L/EQ-5D-Y(proxy) for the patient and their parent. Scale 0-100 (min score: 0, max score :100, higher scores mean a better outcome)
Time Frame
6 and 12 months
Title
Comparison of Adaptive symptoms between the 2 groups
Description
Use the Vineland-II Scale of socio-adaptive behavior measured by the composite score with an average to 100 of 4 dimensions: socialization, communication, life skills everyday life, and motricity (undetermined minimum and maximum composite score, average score : 100, higher scores mean a better outcome)
Time Frame
6 and 12 months
Title
Comparison of Autistic symptoms between the 2 groups
Description
Use the CARS (Child Autism Rating Ladder) scale, 15 items coded from 1 to 4 (score min: 0, max : 60, higher scores mean a worse outcome)
Time Frame
6 and 12 months
Title
Comparison of Social interactions between the 2 groups
Description
Use the SRS (Social Responsiveness Scale) scale, 65 items coded from 1 to 4 (score min: 0 ; score max : 260, higher scores mean a worse outcome)
Time Frame
6 and 12 months
Title
Comparison of Parental Stress between the 2 groups
Description
Use the Parental Stress Index scale, 36 items coded from 1 to 5 (score min : 0 ; max: 180, higher scores mean a worse outcome)
Time Frame
6 and 12 months
Title
The child's acceptability to the e-GOLIAH game at home
Description
interview with clinical team by phone contact every twice a month for 12 months
Time Frame
6 and 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
3 Years
Maximum Age & Unit of Time
6 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria : Child with autism confirmed by a validated instrument (ADI-R or ADOS) Aged 3 to 6 years; Parent(s) agree to get involved in the constraint of using the SG 5 times / week at home for 2 periods of 3 months. Signature of the informed consent form by the 2 holders of parental authority or the only holder of parental authority present Affiliation to a social security scheme (except AME) Non-inclusion criteria : Children with behavioral problems; Unstabilized comorbid organic pathology; Moderate and severe cognitive deficit (Intellectual Quotient less than 55); Multi or polyhandicap. Medication that may cause visual or cognitive impairment (PSAs, neuroleptics, etc.) or that may interfere with the study assessments Degenerative diseases or any other disease that could interfere with the evaluations planned during this study (known epilepsy and/or history of seizures, etc.) Photosensitive persons in order to avoid situations that could induce epileptic seizures in them
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
David COHEN, Professor, Child Psychiatrist
Phone
01 42 16 23 51
Ext
+33
Email
david.cohen@aphp.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Anne BISSERY
Phone
01 42 16 24 32
Ext
+33
Email
anne.bissery@aphp.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David COHEN, Professor
Organizational Affiliation
Assistance Publique - Hôpitaux de Paris
Official's Role
Study Director
Facility Information:
Facility Name
Fondation Lenval - Hôpitaux Pédiatriques de Nice- CHU Lenval
City
Nice
State/Province
Alpes Maritimes
ZIP/Postal Code
06200
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Doctor Suzanne THÜMMLER, Child Psychiatrist
Phone
+33(0)4.92.03.04.39
Email
thummler.s@pediatrie-chulenval-nice.fr
First Name & Middle Initial & Last Name & Degree
Doctor Suzanne THÜMMLER, Child Psychiatrist
Facility Name
Centre Hospitalier Universitaire de Strasbourg
City
Strasbourg
State/Province
Bas-Rhin
ZIP/Postal Code
67091
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Professor Carmen SCHRÖDER, Child Psychiatrist
Phone
+33(0)3.88.11.62.18
Email
schroderc@unistra.fr
First Name & Middle Initial & Last Name & Degree
Professor Carmen SCHRÖDER, Child Psychiatrist
Facility Name
Centre Hospitalier Universitaire de Toulouse
City
Toulouse
State/Province
Haut-Garonne
ZIP/Postal Code
31059
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Professor Jean-Philippe RAYNAUD, Child Psychiatrist
Phone
+33(0)5.61.77.60.55
Email
raynaud.jp@chu-toulouse.fr
First Name & Middle Initial & Last Name & Degree
Professor Jean-Philippe RAYNAUD, Child Psychiatrist
Facility Name
Centre Hospitalier Universitaire de Montpellier
City
Montpellier
State/Province
Hérault
ZIP/Postal Code
34295
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Professor Amaria BAGHDADLI, Child Psychiatrist
Phone
+33(0)4.67.33.96.96
Email
a-baghdadli@chu-montpellier.fr
First Name & Middle Initial & Last Name & Degree
Professor Amaria BAGHDADLI, Child Psychiatrist
Facility Name
Assistance Publique - Hôpitaux de Paris, Site de la Pitié-Salpêtrière
City
Paris
State/Province
Ile De France
ZIP/Postal Code
75013
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Pr David COHEN, Child Psychiatrist
Phone
+33(0)1.42.16.23.51
Email
david.cohen@aphp.fr
First Name & Middle Initial & Last Name & Degree
Isabelle MOREAU-BABILAERE, Secretary
Phone
+33(0)1.42.16.23.51
Email
isabelle.babilaere@aphp.fr
First Name & Middle Initial & Last Name & Degree
David COHEN, Professor, Child Psychiatrist
Facility Name
Centre Hospitalier Sainte-Anne / GHU Paris Psychiatrie et Neurosciences
City
Paris
State/Province
Ile De France
ZIP/Postal Code
75014
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Doctor Catherine DOYEN, Child Psychiatrist
Phone
+33(0)1.45.65.81.24
Email
c.doyen@ch-sainte-anne.fr
First Name & Middle Initial & Last Name & Degree
Doctor Catherine DOYEN, Child Psychiatrist
Facility Name
Assistance Publique - Hôpitaux de Paris, Site de Necker
City
Paris
State/Province
Ile De France
ZIP/Postal Code
75015
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Professor Pauline CHASTE, Child Psychiatrist
Phone
+33(0)1.44.49.45.61
Email
pauline.chaste@aphp.fr
First Name & Middle Initial & Last Name & Degree
Professor Pauline CHASTE, Child Psychiatrist
Facility Name
Centre Hospitalier de Versailles - André Mignot
City
Versailles
State/Province
Ile De France
ZIP/Postal Code
78157
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Professor Mario SPERANZA, Child Psychiatrist
Phone
+33(0)1.39.63.85.43
Email
msperanza@ch-versailles.fr
First Name & Middle Initial & Last Name & Degree
Professor Mario SPERANZA, Child Psychiatrist
Facility Name
Centre Hospitalier Universitaire de Tours
City
Tours
State/Province
Indre-et-Loire
ZIP/Postal Code
37044
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Professor Frédérique BONNET-BRILHAULT, Child Psychiatrist
Phone
+33(0)2.47.47.84.12
Email
frederique.brilhault@univ-tours.fr
First Name & Middle Initial & Last Name & Degree
Professor Frédérique BONNET-BRILHAULT, Child Psychiatrist
Facility Name
Centre Hospitalier Universitaire de Nancy
City
Nancy
State/Province
Meurthe-et-Moselle
ZIP/Postal Code
54511
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Professor Bernard KABUTH, Child Psychiatrist
Phone
+33(0)3.83.15.45.53
Email
bernard.kabuth@cpn-laxou.com
First Name & Middle Initial & Last Name & Degree
Professor Bernard KABUTH, Child Psychiatrist
Facility Name
Centre Hospitalier d'Amiens
City
Amiens
State/Province
Somme
ZIP/Postal Code
80054
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Doctor Xavier BENAROUS, Child Psychiatrist
Phone
+33(0)3.22.82.53.63
Email
benarous.xavier@chu-amiens.fr
First Name & Middle Initial & Last Name & Degree
Doctor Xavier BENAROUS, Child Psychiatrist
Facility Name
Centre Hospitalier Universitaire de Paris - Centre Hospitalier d'Henri Laborit
City
Poitiers
State/Province
Vienne
ZIP/Postal Code
86021
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Professor Jean XAVIER, Child Psychiatrist
Phone
+33(0)5.49.44.57.57
Email
jean.xavier@ch-poitiers.fr
First Name & Middle Initial & Last Name & Degree
Professor Jean XAVIER, Child Psychiatrist

12. IPD Sharing Statement

Citations:
PubMed Identifier
19948568
Citation
Dawson G, Rogers S, Munson J, Smith M, Winter J, Greenson J, Donaldson A, Varley J. Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model. Pediatrics. 2010 Jan;125(1):e17-23. doi: 10.1542/peds.2009-0958. Epub 2009 Nov 30.
Results Reference
background
PubMed Identifier
28344643
Citation
Jouen AL, Narzisi A, Xavier J, Tilmont E, Bodeau N, Bono V, Ketem-Premel N, Anzalone S, Maharatna K, Chetouani M, Muratori F, Cohen D; MICHELANGELO Study Group. GOLIAH (Gaming Open Library for Intervention in Autism at Home): a 6-month single blind matched controlled exploratory study. Child Adolesc Psychiatry Ment Health. 2017 Mar 22;11:17. doi: 10.1186/s13034-017-0154-7. eCollection 2017.
Results Reference
background
PubMed Identifier
28787504
Citation
Bieleninik L, Geretsegger M, Mossler K, Assmus J, Thompson G, Gattino G, Elefant C, Gottfried T, Igliozzi R, Muratori F, Suvini F, Kim J, Crawford MJ, Odell-Miller H, Oldfield A, Casey O, Finnemann J, Carpente J, Park AL, Grossi E, Gold C; TIME-A Study Team. Effects of Improvisational Music Therapy vs Enhanced Standard Care on Symptom Severity Among Children With Autism Spectrum Disorder: The TIME-A Randomized Clinical Trial. JAMA. 2017 Aug 8;318(6):525-535. doi: 10.1001/jama.2017.9478. Erratum In: JAMA. 2021 Apr 13;325(14):1473.
Results Reference
background
PubMed Identifier
29051506
Citation
Billeci L, Narzisi A, Tonacci A, Sbriscia-Fioretti B, Serasini L, Fulceri F, Apicella F, Sicca F, Calderoni S, Muratori F. An integrated EEG and eye-tracking approach for the study of responding and initiating joint attention in Autism Spectrum Disorders. Sci Rep. 2017 Oct 19;7(1):13560. doi: 10.1038/s41598-017-13053-4.
Results Reference
background
PubMed Identifier
27199777
Citation
Bono V, Narzisi A, Jouen AL, Tilmont E, Hommel S, Jamal W, Xavier J, Billeci L, Maharatna K, Wald M, Chetouani M, Cohen D, Muratori F; MICHELANGELO Study Group. GOLIAH: A Gaming Platform for Home-Based Intervention in Autism - Principles and Design. Front Psychiatry. 2016 Apr 28;7:70. doi: 10.3389/fpsyt.2016.00070. eCollection 2016.
Results Reference
background

Learn more about this trial

e-GOLIAH in Autistic Spectrum Disorders

We'll reach out to this number within 24 hrs